Home » Novartis’ Ultibro Breezhaler Reduces COPD Symptoms, Improves Lung Function
Novartis’ Ultibro Breezhaler Reduces COPD Symptoms, Improves Lung Function
Novartis’ dual bronchodilator, Ultibro Breezhaler, showed improvements in lung function and a reduction in chronic obstructive pulmonary disease symptoms.
The study has provided further support to limit the use of inhaled steroid-containing therapies, the company said.
The combination device is approved for use in more than 90 countries. — Cynthia Jessup
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May